Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Clinical trial NCT03597516 · COMPLETED
Trial details
- NCT number
- NCT03597516
- Sponsor
- Ritter Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-26
- Primary completion
- 2019-07-02
- Enrollment
- 557
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.